General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.
Two South Park Street Suite 100 San Francisco, CA 94107
434 Broadway Sixth Floor New York, NY 10013
564 University Avenue Palo Alto, CA 94301
20 University Road Fourth Floor Cambridge, MA 02138
Adrian Abeijon
Investor
Mark Allen
CFO
Neeraj Arora
Managing Director, Investment Team
Juliet Bailin
Principal
Marc Bhargava
Managing Director
Chris Bischoff
Managing Director
Larry Bohn
Managing Director
Teresa Carlson
President, General Catalyst Institute
Kenneth Chenault
Chairman and Managing Director
Quentin Clark
Managing Director
Mark Crane
Partner
Christopher Davis
Partner, Investments
Kyle Doherty
Managing Director
Nick van Eck
Partner
Mina Hsiang
Associate
Nmachi Jidenma
Partner
Christopher Kauffman
Principal
Genevieve Kinney
Principal
Zak Kukoff
Principal
Paul Kwan
Managing Director
Viet Le
Partner
Roy Mabrey
Partner, Investment Team
Holly Maloney McConnell
Managing Director
Karanveer Mohan
Managing Director, Investment Team
Deep Nishar
Managing Director and Member of the Management Committee
Dipchand Nishar
Managing Director
Reva Nohria
Investor
Trevor Oelschig
Managing Director
Tyler Olkowski
Investor
Pranay Orugunta
Healthcare Investor
Mo Punjwani
Associate, Investments
Candace Richardson
Principal
Brian Ru
Principal
Pranav Singhvi
Managing Director
Bill Skarinka
Associate
Alex Tran
Managing Director, Investments
Catherine Tu
Partner, Investment Team
Elena Viboch
Partner
Andrea Wang
Principal, Early Stage Investment
Nathaniel Levy-Westhead
Partner, Investment Team
Past deals in Child Care
Zarminali Health
Seed Round in 2024
Zarminali Health transforms pediatric care by building multispecialty pediatric group that provides modern, seamlessly coordinated care.
Zarminali Health
Debt Financing in 2024
Zarminali Health transforms pediatric care by building multispecialty pediatric group that provides modern, seamlessly coordinated care.
Elemy
Series B in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.
Oath Care
Seed Round in 2021
Oath Care is developing an innovative model of group-based, continuous healthcare aimed at enhancing health outcomes for children. The company operates an online platform that connects medical providers with families, fostering intimate connections and shared parental experiences. Through this platform, users can access specialist support and guidance via group chats and one-on-one video calls. This approach allows patients to receive tailored medical and emotional support, addressing their individual needs effectively.
Elemy
Series A in 2021
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.
Elemy
Seed Round in 2020
Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.